FindTrial
Sign In

A COMPARATIVE STUDY IN TWO DIFFERENT SCALE OF HOMOEOPATHIC MEDICINE IN THE TREATMENT OF MOLLUSCUM CONTAGIOSUM.

A COMPARATIVE STUDY OF 50-MILLESIMAL POTENCIES AND CENTESIMAL POTENCIES IN THE TREATMENT OF MOLLUSCUM CONTAGIOSUM. AN OPEN LABEL, NON RANDOMISED, PROSPECTIVE PILOT TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/04/051295
Enrollment
30
Registered
2023-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Control Intervention1: APPLICATION OF INDIVIDUALISED HOMOEOPATHICMEDICINE IN CENTISIMAL POTENCIES OR 50-MILLESIMAL POTENCIES: APPLICATIOIN CENTISIMAL POTENCIES EACH DOSE SHALL CONSIST OF 4 CANE SUGAR

Sponsors

PRATAP CHANDRA MEMORIAL HOMOEOPATHIC HOSPITAL AND COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.CLINICALLY DIAGNOSED CASES OF MOLLUSCUM CONTAGIOSUM 2.LITERATE PATIENTS ABLE TO READ PATIENT INFORMATION SHEET 3.PARENTS PROVIDING WRITTEN INFORMED CONSENT TO PARTICIPATE

Exclusion criteria

Exclusion criteria: 1. IF PATIENT HAVING ANY OTHER SKIN DISEASES ALONG WITH MOLLUSCUM CONTAGIOSUM 2.PATIENTS HAVE UNDERGONE ORGAN TRANSPLANTATION 3.PATIENTS USING IMMUNOSUPPRESIVE MEDICATION 4.PATIENTS USING STEROIDS 5.CASES ALREADY UNDERGOING HOMOEOPATHIC TREATMENT FOR ANY CHRONIC PURPOSE

Design outcomes

Primary

MeasureTime frame
1.TO EVALUATE THE IMPROVEMENT OF MOLLUSCUM CONTAGIOSUM PATIENT TREATED BY INDIVIDUALISED HOMOEOPATHIC APPROACH BY USING TWO DIFFERENT POTENCY SCALES 2.TO EVALUATE THE ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN IMPROVEMENT OF QUALITY OF LIFE USING DERMATOLOGY LIFE QUALITY INDEX (DLQI) IN BOTH THE SCALES 3.COMPARE THE IMPROVEMENT IN BOTH 50-MILLESIMAL AND CENTISIMAL SCALESTimepoint: BASELINE AND THREE MONTHS—

Secondary

MeasureTime frame
DLQI SCALETimepoint: BASELINE AND SIX MONTHS—

Countries

India

Contacts

Public ContactDEB KUMAR PALIT

PRATAP CHANDRA MEMORIAL HOMOEOPATHIC HOSPITAL AND COLLEGE

imdrpalit@gmail.com9804445261

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026